how many people use glp 1 Insights from Specialty Physicians on GLP-1RA Medications Off-Label GLP-1 drugs don't work for

Semaglutide works by: Enhancing insulin secretion in a glucose-dependent manner, which helps regulate blood sugar levels Suppressing glucagon release , reducing hepatic glucose output Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects led to significant weight loss in clinical trials (STEP programme), typically in the range of 1015% of body weight over 68 weeks, though individual results vary considerably

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity

It boosts the bodys defenses, safeguards cells against harm, and benefits the skin in several ways

Most will lessen over time